Skip to content

Effectiveness Evaluation of a Dengue Self-monitoring System

Effectiveness Evaluation of a Dengue Self-monitoring System (DeSMoS) to Reduce Treatment Delay in Malaysia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05688748
Acronym
DeSMoS
Enrollment
37
Registered
2023-01-18
Start date
2023-01-20
Completion date
2023-06-30
Last updated
2023-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dengue

Keywords

dengue, outpatient care, self-monitoring system, treatment delay, warning symptoms

Brief summary

The goal of this clinical trial is to compare the effectiveness of a dengue self-monitoring system with standard care in reducing treatment delay among dengue patients receiving outpatient care. The main question it aims to answer are: • Is a dengue self-monitoring system effective in reducing treatment delay in dengue patients? Participants will use the dengue monitoring system in addition to the standard care they are receiving for outpatient follow up for dengue. Researchers will compare them with dengue patients receiving the usual standard care to see if the dengue monitoring system reduces delay in treatment seeking in patients.

Detailed description

Dengue Self-Monitoring System (DeSMoS) was developed to guide patients about warning signs and advise them to visit a doctor appropriately before their scheduled follow up on the next day, apart from motivating them to comply to the daily follow up visits at the clinic. DeSMoS is hypothesised to effectively reduce delay in treatment seeking in dengue patients. The main aim of this system is to get dengue patients to key-in their symptoms regularly via the app when they are at home. Reminders will appear on the phone to remind them to key in the symptoms thrice daily. The system is designed as a supportive tool for outpatient dengue management. It is not meant to replace to usual standard care for dengue care.

Interventions

OTHERDengue self-monitoring system

The system has a symptom monitoring algorithm whereby patient would be asked to report their symptoms thrice daily (9am, 2pm and 8pm). The algorithm is developed by the researchers which consist of primary care doctors, emergency physician and infectious disease specialists. If the patient reports warning symptoms (persistent vomiting, persistent diarrhoea, abdominal pain, bleeding, difficulty breathing, feel like fainting, difficulty carrying out usual activities, drowsiness, reduced urine output and reduced urine output), the system will advise patients to seek earlier medical care instead of waiting for the scheduled appointment the next day/other days.

Sponsors

Ministry of Health, Malaysia
CollaboratorOTHER_GOV
University of Malaya
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years old and above * Newly diagnosed with dengue fever * Have a smartphone * Receiving outpatient follow up for dengue

Exclusion criteria

* Hearing and speech impairment * Cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Reduction in treatment delayUp to two weeksProportion of patients with warning symptoms who return to see a doctor earlier than scheduled

Secondary

MeasureTime frameDescription
Compliance to follow upUp to two weeksProportion of patients who are compliant of all follow up visits
Development of warning symptomsUp to two weeksProportion of patients who develop warning symptoms
HospitalizationUp to two weeksProportion of patients with warning symptoms who are admitted to hospital

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026